Abstract:To the Editor: Patent foramen ovale (PFO) is present in 20% to 35% of the population, and its prevalence varies with age.1 In an old but still valid echocardiographic study PFO incidence in patients aged 70 to 79 was approximately half that of patients aged 40 to 49 but still important (6.15%).2 Moreover, the risk of adverse cerebral events in patients aged 65 and older was significantly higher in the patients with PFO (P=.01, hazard ratio=3.21, 95% confidence interfal (CI)=1.33–7.75; 2-year event rates 37.9% vs 14.5%).3 The increase in life expectancy makes the diagnosis of PFO a possible and not easily manageable event in patients aged 60 and older; the presence of different comorbidities and in particular of diastolic dysfunction could be a serious contraindication to PFO closure. We propose a simple algorythm for managing elderly patients with PFO based on a few considerations. First, elderly patients cannot be excluded from PFO closure a priori based on age. Second, medium-to-large PFOs, especially if associated with a large persistent Eustachian valve or Chiari network, can frequently embolize and cause recurrent stroke in patients aged 60 and older; moreover, in elderly people, PFO may be the cause of other syndromes, including unexplained hypoxemia, hypoxemia after lung surgery, and hypoxemia associated with sleep apnea syndrome, which can all benefit from transcathter closure.4,5 Third, careful evaluation of carotid and aortic atherosclerotic plaques, and especially of diastolic dysfunction, should be employed before any closure attempt; soft carotid plaques or Montgomery Class III or greater aortic plaques or Class III or greater diastolic dysfunction should be considered as absolute contraindications. Occlusion test with a sizing balloon without worsening of left ventricle function suggests that closure in patients with mild diastolic dysfunction can be performed safely. Fourth, elderly patients should be evaluated using an integrated protocol including a stress test to evaluate coronary artery disease. Finally, only selected elderly patients evaluated with similar protocols can proceed safely to PFO closure (Figure 1). Suggested management of elderly patients with significant patent foramen ovale (PFO). TEE= transesophageal echocardiograph. Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the author and has determined that none of the authors have any financial or any other kind of personal conflicts with this letter. Dr. Gianluca Rigatelli is a consultant for St. Jude Medical Corp. (<1,000 euro per year). Author Contributions: Gianluca Rigatelli is the only author. Sponsor's Role: None.

Asymptomatic Significant Patent Foramen Ovale: Giving Patent Foramen Ovale Management Back to the Cardiologist

Patent Foramen Ovale: a Comprehensive Review for Pulmonologists

Patent Foramen Ovale Management: Who Should Do What?

Patent Foramen Ovale: the Evident Paradox Between the Apparently Simple Treatment and the Really Complex Pathophysiology

Patent Foramen Ovale with Paradoxical Embolism: Mid‐Term Results of Transcatheter Closure in 256 Patients

Transcatheters for Closure of Patent Foramen Ovales

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Transcatheters for Closure of Patent Foramen Ovales.

[Patent Foramen Ovale: a Benign Anatomical Variant That Can Become a Disease].

Patent Foramen Ovale Closure for Nonstroke Indications

Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: a Collaborative, Multidisciplinary, Position Paper.

ICE-guided Patent Foramen Ovale (PFO) Closure with Lastest-Generation Devices: the Ideal Strategy for PFO-related Migraine?

Recent Advances in Catheter Devices for Patent Foramen Ovale Closure

PATENT FORAMEN OVALE IN ELDERLY PEOPLE

Patent foramen ovale in the elderly: what to do?

Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.

Contemporary Management of Patent Foramen Ovale in Patients Undergoing Ventricular Assisting Devices or Heart Transplantation

Patent Foramen Ovale Closure in Special Clinical Situations: More Questions Than Answers?

Improving Migraine by Means of Primary Transcatheter Patent Foramen Ovale Closure: Long-Term Follow-Up.

Patent Foramen Ovale-Mania: an Unusual Case of Misdiagnosis.

Permanent Right-to-left Shunt is the Key Factor in Managing Patent Foramen Ovale.